Bortezomib and Pemetrexed Disodium in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors

Clinical trial NCT00389805 · COMPLETED

Trial details

NCT number: NCT00389805
Sponsor: University of California, Davis
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Lung Cancer Unspecified Adult Solid Tumor, Protocol Specific

Start date: 2005-03-01
Primary completion: 2006-12-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.